TScan Therapeutics Inc —— 现金流量表 (NASDAQ:TCRX) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -48.68 M-66.5 M-61.36 M-110.82 M-135.32 M -135.32 M 投资活动产生的现金 -9.94 M-4.22 M-60.76 M-52.61 M109.37 M 109.37 M 融资活动产生的现金 189.67 M29.36 M135.44 M208.76 M-336 K -336 K 自由现金流 -58.62 M-70.73 M-64.5 M-114.65 M-139.73 M -139.73 M

新闻

Buy 2 ‘Strong Buy’ Biotech Stocks With 400%+ Upside, According to Wall Street - TipRanks.com

Tscan TherapeuticsQ1每股收益及营收超出预期

Tscan Therapeutics earnings beat by $0.09, revenue topped estimates

TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Misses Revenue Estimates

TScan completes enrollment in trial cohort, receives FDA clearance

Recursion Pharmaceuticals (RXRX) Reports Q4 Loss, Beats Revenue Estimates

Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Beats Revenue Estimates

Sutro Biopharma (STRO) Surges 11.9%: Is This an Indication of Further Gains?

Roivant Sciences Ltd. (ROIV) Reports Q3 Loss, Misses Revenue Estimates

Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)

BTIG在ASH活动后维持Tscan Therapeutics股票中性评级

Tscan Therapeutics stock holds Neutral rating at BTIG after ASH event